A 12-Week, Randomized, Double-Masked Study of Fixed Combination Latanoprost/Timolol versus Latanoprost or Timolol Monotherapy

Collaboration types: Industry collaboration; Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.36 Ophthalmology; 1.36.226 Glaucoma
Web Of Science research areas: Ophthalmology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Title: A 12-Week, Randomized, Double-Masked Study of Fixed Combination Latanoprost/Timolol versus Latanoprost or Timolol Monotherapy
Creators: Paul Palmberg - University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, Florida
Elizabeth E Kim - Pfizer Inc., New York, New York, Mount Sinai School of Medicine, New York, New York
Kenneth K Kwok - Pfizer Inc., New York, New York
Charles S Tressler - Pfizer Inc., New York, New York, Uniformed Services University of the Health Sciences, Bethesda, Maryland - USA
Publication Details: European journal of ophthalmology, Vol.20(4), pp.708-718
Academic Unit: Miller School of Medicine; UMMG Department of Ophthalmology
Language: English
Resource Type: Journal article
PMID: 20099236
Record Identifier: 991031562707402976